NOVOSIS PUTTY, previously designated as a Breakthrough Device by the FDA in December 2023, leverages novel technology to address unmet needs in bone regeneration. This milestone marks NOVOSIS ...

On Tuesday 25 March GAK's bright yellow bricks-and-mortar store on Brighton's North Road failed to open, instead displaying a message which read: "Closed for maintenance. We apologise for the ...

The approval by the US Food and Drug Administration marks a major milestone, making Novosis Putty the first Korean-developed bone graft substitute to enter pivotal clinical trials in the US.